ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prescription Weight Loss Pills Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4Z14657
Home | Market Reports | Beauty & Fitness| Weight Loss
Global Prescription Weight Loss Pills Market Research Report 2023
BUY CHAPTERS

Global Prescription Weight Loss Pills Market Research Report 2025

Code: QYRE-Auto-4Z14657
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk A S
Pfizer Inc
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)

Prescription Weight Loss Pills Market Size

The global market for Prescription Weight Loss Pills was valued at US$ 1586 million in the year 2024 and is projected to reach a revised size of US$ 3140 million by 2031, growing at a CAGR of 10.4% during the forecast period.

Prescription Weight Loss Pills Market

Prescription Weight Loss Pills Market

Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
Rising conditions such as obesity, cardiovascular diseases, diabetes, and hypertension are increasing the revenue share of the global weight loss drugs market. Moreover, these drugs are used to maintain a healthy body weight amid growing adoption of a healthy lifestyle, thereby driving the expansion of the market revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prescription Weight Loss Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Weight Loss Pills.
The Prescription Weight Loss Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prescription Weight Loss Pills market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Weight Loss Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prescription Weight Loss Pills Market Report

Report Metric Details
Report Name Prescription Weight Loss Pills Market
Accounted market size in year US$ 1586 million
Forecasted market size in 2031 US$ 3140 million
CAGR 10.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral Tablets
  • Oral Capsules
  • Injections
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree), Eli Lilly and Company (TRICARE), CHEPLAPHARM (Xenical), Pfizer, Teva Pharmaceutical (Actavis), Haleon Group (alli), Sanofi (Adlyxin), AstraZeneca (BYDUREON BCise)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prescription Weight Loss Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Prescription Weight Loss Pills Market growing?

Ans: The Prescription Weight Loss Pills Market witnessing a CAGR of 10.4% during the forecast period 2025-2031.

What is the Prescription Weight Loss Pills Market size in 2031?

Ans: The Prescription Weight Loss Pills Market size in 2031 will be US$ 3140 million.

Who are the main players in the Prescription Weight Loss Pills Market report?

Ans: The main players in the Prescription Weight Loss Pills Market are Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree), Eli Lilly and Company (TRICARE), CHEPLAPHARM (Xenical), Pfizer, Teva Pharmaceutical (Actavis), Haleon Group (alli), Sanofi (Adlyxin), AstraZeneca (BYDUREON BCise)

What are the Application segmentation covered in the Prescription Weight Loss Pills Market report?

Ans: The Applications covered in the Prescription Weight Loss Pills Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Prescription Weight Loss Pills Market report?

Ans: The Types covered in the Prescription Weight Loss Pills Market report are Oral Tablets, Oral Capsules, Injections

1 Prescription Weight Loss Pills Market Overview
1.1 Product Definition
1.2 Prescription Weight Loss Pills by Type
1.2.1 Global Prescription Weight Loss Pills Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Tablets
1.2.3 Oral Capsules
1.2.4 Injections
1.3 Prescription Weight Loss Pills by Application
1.3.1 Global Prescription Weight Loss Pills Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Prescription Weight Loss Pills Market Size Estimates and Forecasts
1.4.1 Global Prescription Weight Loss Pills Revenue 2020-2031
1.4.2 Global Prescription Weight Loss Pills Sales 2020-2031
1.4.3 Global Prescription Weight Loss Pills Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prescription Weight Loss Pills Market Competition by Manufacturers
2.1 Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prescription Weight Loss Pills Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prescription Weight Loss Pills, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Weight Loss Pills, Product Type & Application
2.7 Global Key Manufacturers of Prescription Weight Loss Pills, Date of Enter into This Industry
2.8 Global Prescription Weight Loss Pills Market Competitive Situation and Trends
2.8.1 Global Prescription Weight Loss Pills Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prescription Weight Loss Pills Players Market Share by Revenue
2.8.3 Global Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prescription Weight Loss Pills Market Scenario by Region
3.1 Global Prescription Weight Loss Pills Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prescription Weight Loss Pills Sales by Region: 2020-2031
3.2.1 Global Prescription Weight Loss Pills Sales by Region: 2020-2025
3.2.2 Global Prescription Weight Loss Pills Sales by Region: 2026-2031
3.3 Global Prescription Weight Loss Pills Revenue by Region: 2020-2031
3.3.1 Global Prescription Weight Loss Pills Revenue by Region: 2020-2025
3.3.2 Global Prescription Weight Loss Pills Revenue by Region: 2026-2031
3.4 North America Prescription Weight Loss Pills Market Facts & Figures by Country
3.4.1 North America Prescription Weight Loss Pills Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prescription Weight Loss Pills Sales by Country (2020-2031)
3.4.3 North America Prescription Weight Loss Pills Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prescription Weight Loss Pills Market Facts & Figures by Country
3.5.1 Europe Prescription Weight Loss Pills Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prescription Weight Loss Pills Sales by Country (2020-2031)
3.5.3 Europe Prescription Weight Loss Pills Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Weight Loss Pills Market Facts & Figures by Region
3.6.1 Asia Pacific Prescription Weight Loss Pills Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prescription Weight Loss Pills Sales by Region (2020-2031)
3.6.3 Asia Pacific Prescription Weight Loss Pills Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prescription Weight Loss Pills Market Facts & Figures by Country
3.7.1 Latin America Prescription Weight Loss Pills Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prescription Weight Loss Pills Sales by Country (2020-2031)
3.7.3 Latin America Prescription Weight Loss Pills Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prescription Weight Loss Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Weight Loss Pills Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prescription Weight Loss Pills Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prescription Weight Loss Pills Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prescription Weight Loss Pills Sales by Type (2020-2031)
4.1.1 Global Prescription Weight Loss Pills Sales by Type (2020-2025)
4.1.2 Global Prescription Weight Loss Pills Sales by Type (2026-2031)
4.1.3 Global Prescription Weight Loss Pills Sales Market Share by Type (2020-2031)
4.2 Global Prescription Weight Loss Pills Revenue by Type (2020-2031)
4.2.1 Global Prescription Weight Loss Pills Revenue by Type (2020-2025)
4.2.2 Global Prescription Weight Loss Pills Revenue by Type (2026-2031)
4.2.3 Global Prescription Weight Loss Pills Revenue Market Share by Type (2020-2031)
4.3 Global Prescription Weight Loss Pills Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prescription Weight Loss Pills Sales by Application (2020-2031)
5.1.1 Global Prescription Weight Loss Pills Sales by Application (2020-2025)
5.1.2 Global Prescription Weight Loss Pills Sales by Application (2026-2031)
5.1.3 Global Prescription Weight Loss Pills Sales Market Share by Application (2020-2031)
5.2 Global Prescription Weight Loss Pills Revenue by Application (2020-2031)
5.2.1 Global Prescription Weight Loss Pills Revenue by Application (2020-2025)
5.2.2 Global Prescription Weight Loss Pills Revenue by Application (2026-2031)
5.2.3 Global Prescription Weight Loss Pills Revenue Market Share by Application (2020-2031)
5.3 Global Prescription Weight Loss Pills Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Currax Pharmaceuticals (Contrave)
6.1.1 Currax Pharmaceuticals (Contrave) Company Information
6.1.2 Currax Pharmaceuticals (Contrave) Description and Business Overview
6.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
6.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
6.2 VIVUS (Qsymia)
6.2.1 VIVUS (Qsymia) Company Information
6.2.2 VIVUS (Qsymia) Description and Business Overview
6.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
6.2.5 VIVUS (Qsymia) Recent Developments/Updates
6.3 Novo Nordisk A/S
6.3.1 Novo Nordisk A/S Company Information
6.3.2 Novo Nordisk A/S Description and Business Overview
6.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
6.3.5 Novo Nordisk A/S Recent Developments/Updates
6.4 Rhythm Pharmaceuticals (Imcivree)
6.4.1 Rhythm Pharmaceuticals (Imcivree) Company Information
6.4.2 Rhythm Pharmaceuticals (Imcivree) Description and Business Overview
6.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
6.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
6.5 Eli Lilly and Company (TRICARE)
6.5.1 Eli Lilly and Company (TRICARE) Company Information
6.5.2 Eli Lilly and Company (TRICARE) Description and Business Overview
6.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
6.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
6.6 CHEPLAPHARM (Xenical)
6.6.1 CHEPLAPHARM (Xenical) Company Information
6.6.2 CHEPLAPHARM (Xenical) Description and Business Overview
6.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
6.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Prescription Weight Loss Pills Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical (Actavis)
6.8.1 Teva Pharmaceutical (Actavis) Company Information
6.8.2 Teva Pharmaceutical (Actavis) Description and Business Overview
6.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
6.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
6.9 Haleon Group (alli)
6.9.1 Haleon Group (alli) Company Information
6.9.2 Haleon Group (alli) Description and Business Overview
6.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
6.9.5 Haleon Group (alli) Recent Developments/Updates
6.10 Sanofi (Adlyxin)
6.10.1 Sanofi (Adlyxin) Company Information
6.10.2 Sanofi (Adlyxin) Description and Business Overview
6.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
6.10.5 Sanofi (Adlyxin) Recent Developments/Updates
6.11 AstraZeneca (BYDUREON BCise)
6.11.1 AstraZeneca (BYDUREON BCise) Company Information
6.11.2 AstraZeneca (BYDUREON BCise) Description and Business Overview
6.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2020-2025)
6.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
6.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prescription Weight Loss Pills Industry Chain Analysis
7.2 Prescription Weight Loss Pills Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Weight Loss Pills Production Mode & Process Analysis
7.4 Prescription Weight Loss Pills Sales and Marketing
7.4.1 Prescription Weight Loss Pills Sales Channels
7.4.2 Prescription Weight Loss Pills Distributors
7.5 Prescription Weight Loss Pills Customer Analysis
8 Prescription Weight Loss Pills Market Dynamics
8.1 Prescription Weight Loss Pills Industry Trends
8.2 Prescription Weight Loss Pills Market Drivers
8.3 Prescription Weight Loss Pills Market Challenges
8.4 Prescription Weight Loss Pills Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk A S
Pfizer Inc
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)
List of Tables
 Table 1. Global Prescription Weight Loss Pills Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prescription Weight Loss Pills Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prescription Weight Loss Pills Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prescription Weight Loss Pills Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prescription Weight Loss Pills Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prescription Weight Loss Pills Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prescription Weight Loss Pills Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prescription Weight Loss Pills, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prescription Weight Loss Pills, Product Type & Application
 Table 12. Global Key Manufacturers of Prescription Weight Loss Pills, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prescription Weight Loss Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Weight Loss Pills as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prescription Weight Loss Pills Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prescription Weight Loss Pills Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prescription Weight Loss Pills Sales Market Share by Region (2020-2025)
 Table 19. Global Prescription Weight Loss Pills Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prescription Weight Loss Pills Sales Market Share by Region (2026-2031)
 Table 21. Global Prescription Weight Loss Pills Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prescription Weight Loss Pills Revenue Market Share by Region (2020-2025)
 Table 23. Global Prescription Weight Loss Pills Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prescription Weight Loss Pills Revenue Market Share by Region (2026-2031)
 Table 25. North America Prescription Weight Loss Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prescription Weight Loss Pills Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prescription Weight Loss Pills Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prescription Weight Loss Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prescription Weight Loss Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prescription Weight Loss Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prescription Weight Loss Pills Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prescription Weight Loss Pills Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prescription Weight Loss Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prescription Weight Loss Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prescription Weight Loss Pills Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prescription Weight Loss Pills Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prescription Weight Loss Pills Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prescription Weight Loss Pills Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prescription Weight Loss Pills Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prescription Weight Loss Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prescription Weight Loss Pills Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prescription Weight Loss Pills Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prescription Weight Loss Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prescription Weight Loss Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prescription Weight Loss Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prescription Weight Loss Pills Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prescription Weight Loss Pills Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prescription Weight Loss Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prescription Weight Loss Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prescription Weight Loss Pills Sales (K Units) by Type (2020-2025)
 Table 51. Global Prescription Weight Loss Pills Sales (K Units) by Type (2026-2031)
 Table 52. Global Prescription Weight Loss Pills Sales Market Share by Type (2020-2025)
 Table 53. Global Prescription Weight Loss Pills Sales Market Share by Type (2026-2031)
 Table 54. Global Prescription Weight Loss Pills Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prescription Weight Loss Pills Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prescription Weight Loss Pills Revenue Market Share by Type (2020-2025)
 Table 57. Global Prescription Weight Loss Pills Revenue Market Share by Type (2026-2031)
 Table 58. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prescription Weight Loss Pills Sales (K Units) by Application (2020-2025)
 Table 61. Global Prescription Weight Loss Pills Sales (K Units) by Application (2026-2031)
 Table 62. Global Prescription Weight Loss Pills Sales Market Share by Application (2020-2025)
 Table 63. Global Prescription Weight Loss Pills Sales Market Share by Application (2026-2031)
 Table 64. Global Prescription Weight Loss Pills Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prescription Weight Loss Pills Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prescription Weight Loss Pills Revenue Market Share by Application (2020-2025)
 Table 67. Global Prescription Weight Loss Pills Revenue Market Share by Application (2026-2031)
 Table 68. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2026-2031)
 Table 70. Currax Pharmaceuticals (Contrave) Company Information
 Table 71. Currax Pharmaceuticals (Contrave) Description and Business Overview
 Table 72. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product
 Table 74. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
 Table 75. VIVUS (Qsymia) Company Information
 Table 76. VIVUS (Qsymia) Description and Business Overview
 Table 77. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. VIVUS (Qsymia) Prescription Weight Loss Pills Product
 Table 79. VIVUS (Qsymia) Recent Developments/Updates
 Table 80. Novo Nordisk A/S Company Information
 Table 81. Novo Nordisk A/S Description and Business Overview
 Table 82. Novo Nordisk A/S Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novo Nordisk A/S Prescription Weight Loss Pills Product
 Table 84. Novo Nordisk A/S Recent Developments/Updates
 Table 85. Rhythm Pharmaceuticals (Imcivree) Company Information
 Table 86. Rhythm Pharmaceuticals (Imcivree) Description and Business Overview
 Table 87. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product
 Table 89. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
 Table 90. Eli Lilly and Company (TRICARE) Company Information
 Table 91. Eli Lilly and Company (TRICARE) Description and Business Overview
 Table 92. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product
 Table 94. Eli Lilly and Company (TRICARE) Recent Developments/Updates
 Table 95. CHEPLAPHARM (Xenical) Company Information
 Table 96. CHEPLAPHARM (Xenical) Description and Business Overview
 Table 97. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product
 Table 99. CHEPLAPHARM (Xenical) Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Prescription Weight Loss Pills Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Teva Pharmaceutical (Actavis) Company Information
 Table 106. Teva Pharmaceutical (Actavis) Description and Business Overview
 Table 107. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product
 Table 109. Teva Pharmaceutical (Actavis) Recent Developments/Updates
 Table 110. Haleon Group (alli) Company Information
 Table 111. Haleon Group (alli) Description and Business Overview
 Table 112. Haleon Group (alli) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Haleon Group (alli) Prescription Weight Loss Pills Product
 Table 114. Haleon Group (alli) Recent Developments/Updates
 Table 115. Sanofi (Adlyxin) Company Information
 Table 116. Sanofi (Adlyxin) Description and Business Overview
 Table 117. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sanofi (Adlyxin) Prescription Weight Loss Pills Product
 Table 119. Sanofi (Adlyxin) Recent Developments/Updates
 Table 120. AstraZeneca (BYDUREON BCise) Company Information
 Table 121. AstraZeneca (BYDUREON BCise) Description and Business Overview
 Table 122. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product
 Table 124. AstraZeneca (BYDUREON BCise) Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Prescription Weight Loss Pills Distributors List
 Table 128. Prescription Weight Loss Pills Customers List
 Table 129. Prescription Weight Loss Pills Market Trends
 Table 130. Prescription Weight Loss Pills Market Drivers
 Table 131. Prescription Weight Loss Pills Market Challenges
 Table 132. Prescription Weight Loss Pills Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prescription Weight Loss Pills
 Figure 2. Global Prescription Weight Loss Pills Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prescription Weight Loss Pills Market Share by Type: 2024 & 2031
 Figure 4. Oral Tablets Product Picture
 Figure 5. Oral Capsules Product Picture
 Figure 6. Injections Product Picture
 Figure 7. Global Prescription Weight Loss Pills Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Prescription Weight Loss Pills Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Pharmacy
 Figure 11. Global Prescription Weight Loss Pills Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Prescription Weight Loss Pills Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Prescription Weight Loss Pills Sales (2020-2031) & (K Units)
 Figure 14. Global Prescription Weight Loss Pills Average Price (US$/Unit) & (2020-2031)
 Figure 15. Prescription Weight Loss Pills Report Years Considered
 Figure 16. Prescription Weight Loss Pills Sales Share by Manufacturers in 2024
 Figure 17. Global Prescription Weight Loss Pills Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Prescription Weight Loss Pills Players: Market Share by Revenue in Prescription Weight Loss Pills in 2024
 Figure 19. Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Prescription Weight Loss Pills Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Prescription Weight Loss Pills Sales Market Share by Country (2020-2031)
 Figure 22. North America Prescription Weight Loss Pills Revenue Market Share by Country (2020-2031)
 Figure 23. United States Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Prescription Weight Loss Pills Sales Market Share by Country (2020-2031)
 Figure 26. Europe Prescription Weight Loss Pills Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Prescription Weight Loss Pills Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Prescription Weight Loss Pills Revenue Market Share by Region (2020-2031)
 Figure 34. China Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Prescription Weight Loss Pills Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Prescription Weight Loss Pills Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Prescription Weight Loss Pills Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Prescription Weight Loss Pills Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Prescription Weight Loss Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Prescription Weight Loss Pills by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Prescription Weight Loss Pills by Type (2020-2031)
 Figure 53. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Prescription Weight Loss Pills by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Prescription Weight Loss Pills by Application (2020-2031)
 Figure 56. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2020-2031)
 Figure 57. Prescription Weight Loss Pills Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Anti Obesity Drugs Anti obesity Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long acting Weight Loss Drugs Market Research Report 2024
Global Weight Control Medication Market Research Report 2024
Anti Obesity Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Weight Loss Medications Market Research Report 2025
Global Weight Loss Programs Market Research Report 2024
Anti obesity Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Obesity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Weight Loss Drug Market Research Report 2024
Global BMI Machine Market Insights Forecast to 2030
Global Diet Pill Market Insights Forecast to 2030
Global Oral Anorexiant Drug Market Research Report 2024
Global Weight Loss Medicine Orlistat Market Research Report 2024
Global Genetic Obesity Drug Market Research Report 2025
Global Weight loss Drugs Market Insights Forecast to 2030
Global GLP 1 Weight Loss Pill Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
FDA Grade Weight Loss Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peripherally Acting Anti Obesity Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Reduction Medicine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions